The Symptoms and Clinical Manifestations Observed in COVID-19 Patients/Long COVID-19 Symptoms that Parallel Toxoplasma gondii Infections.
作者信息
Roe Kevin
机构信息
, San Jose, CA, USA.
出版信息
J Neuroimmune Pharmacol. 2021 Sep;16(3):513-516. doi: 10.1007/s11481-021-09997-0. Epub 2021 May 29.
Abstract
摘要
相似文献
1
The Symptoms and Clinical Manifestations Observed in COVID-19 Patients/Long COVID-19 Symptoms that Parallel Toxoplasma gondii Infections.
J Neuroimmune Pharmacol. 2021 Sep;16(3):513-516. doi: 10.1007/s11481-021-09997-0. Epub 2021 May 29.
2
A role for T-cell exhaustion in Long COVID-19 and severe outcomes for several categories of COVID-19 patients.
J Neurosci Res. 2021 Oct;99(10):2367-2376. doi: 10.1002/jnr.24917. Epub 2021 Jul 19.
3
The link between Toxoplasma gondii infections and higher mortality in COVID-19 patients having schizophrenia.
Eur Arch Psychiatry Clin Neurosci. 2022 Feb;272(1):167-168. doi: 10.1007/s00406-021-01341-0. Epub 2021 Oct 4.
4
A comparison of two methods of gene amplification for the diagnosis of Toxoplasma gondii in AIDS.
J Infect. 1996 Nov;33(3):177-83. doi: 10.1016/s0163-4453(96)92201-x.
5
Toxoplasmosis is a risk factor for acquiring SARS-CoV-2 infection and a severe course of COVID-19 in the Czech and Slovak population: a preregistered exploratory internet cross-sectional study.
Parasit Vectors. 2021 Sep 28;14(1):508. doi: 10.1186/s13071-021-05021-9.
6
Sero-prevalence of Toxoplasma gondii before and during the COVID-19 pandemic in Northwestern Iran.
BMC Infect Dis. 2024 Aug 16;24(1):834. doi: 10.1186/s12879-024-09724-z.
7
[Toxoplasma gondii: a potential role in the genesis of psychiatric disorders].
Encephale. 2013 Feb;39(1):38-43. doi: 10.1016/j.encep.2012.06.014. Epub 2012 Aug 21.
8
Is COVID-19 associated with latent toxoplasmosis?
Environ Sci Pollut Res Int. 2021 Dec;28(47):67886-67890. doi: 10.1007/s11356-021-17126-w. Epub 2021 Oct 25.
9
Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis.
J Infect Dis. 2002 Feb 15;185 Suppl 1:S73-82. doi: 10.1086/338827.
10
Genotyping of Toxoplasma gondii: DNA extraction from formalin-fixed paraffin-embedded autopsy tissues from AIDS patients who died by severe disseminated toxoplasmosis.
Exp Parasitol. 2016 Jun;165:16-21. doi: 10.1016/j.exppara.2016.03.004. Epub 2016 Mar 10.
引用本文的文献
1
Seroepidemiology and Risk Factors of in Iranian COVID-19 Patients: A Case-Control Study.
Iran J Parasitol. 2025 Jan-Mar;20(1):140-147. doi: 10.18502/ijpa.v20i1.18114.
2
Multifunctional nanoparticles: Antimicrobial, antiviral, antiparasitic and anti-inflammatory activities.
Heliyon. 2025 Jan 16;11(2):e42044. doi: 10.1016/j.heliyon.2025.e42044. eCollection 2025 Jan 30.
3
Ocular Toxoplasmosis: Advances in Biology, Clinical Manifestations, Diagnostics, and Therapy.
Pathogens. 2024 Oct 14;13(10):898. doi: 10.3390/pathogens13100898.
4
Impact of latent toxoplasmosis on pneumonic and non-pneumonic COVID-19 patients with estimation of relevant oxidative stress biomarkers.
Folia Parasitol (Praha). 2024 Apr 4;71:2024.008. doi: 10.14411/fp.2024.008.
5
Genetic diversity and seroprevalence of Toxoplasma gondii in COVID‑19 patients; a first case-control study in Iran.
BMC Infect Dis. 2024 Jan 3;24(1):42. doi: 10.1186/s12879-023-08964-9.
6
Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges.
Int J Mol Sci. 2023 Jun 21;24(13):10458. doi: 10.3390/ijms241310458.
7
Molecular Detection of , and spp. in Vespertilionid Bats from Central Europe.
Int J Mol Sci. 2023 Jun 8;24(12):9887. doi: 10.3390/ijms24129887.
8
Plasma cell-free RNA characteristics in COVID-19 patients.
Genome Res. 2022 Feb;32(2):228-241. doi: 10.1101/gr.276175.121. Epub 2022 Jan 21.
9
COVID-19-associated opportunistic infections: a snapshot on the current reports.
Clin Exp Med. 2022 Aug;22(3):327-346. doi: 10.1007/s10238-021-00751-7. Epub 2021 Aug 23.
10
A role for T-cell exhaustion in Long COVID-19 and severe outcomes for several categories of COVID-19 patients.
J Neurosci Res. 2021 Oct;99(10):2367-2376. doi: 10.1002/jnr.24917. Epub 2021 Jul 19.
本文引用的文献
1
Association of Psychiatric Disorders With Mortality Among Patients With COVID-19.
JAMA Psychiatry. 2021 Apr 1;78(4):380-386. doi: 10.1001/jamapsychiatry.2020.4442.
2
Long-COVID: An evolving problem with an extensive impact.
S Afr Med J. 2020 Nov 23;111(1):10-12. doi: 10.7196/SAMJ.2020.v111i11.15433.
3
Long COVID-19-it's not over until?
Clin Microbiol Infect. 2021 Apr;27(4):506-508. doi: 10.1016/j.cmi.2020.12.001. Epub 2020 Dec 11.
4
Follow-up of adults with noncritical COVID-19 two months after symptom onset.
Clin Microbiol Infect. 2021 Feb;27(2):258-263. doi: 10.1016/j.cmi.2020.09.052. Epub 2020 Oct 5.
5
Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis.
PLoS Med. 2020 Sep 10;17(9):e1003321. doi: 10.1371/journal.pmed.1003321. eCollection 2020 Sep.
6
Overweight, obesity, and risk of hospitalization for COVID-19: A community-based cohort study of adults in the United Kingdom.
Proc Natl Acad Sci U S A. 2020 Sep 1;117(35):21011-21013. doi: 10.1073/pnas.2011086117. Epub 2020 Aug 11.
7
Clinical Course and Factors Associated With Hospitalization and Critical Illness Among COVID-19 Patients in Chicago, Illinois.
Acad Emerg Med. 2020 Oct;27(10):963-973. doi: 10.1111/acem.14104. Epub 2020 Aug 25.
8
The COVID-19 Global Pandemic: Implications for People With Schizophrenia and Related Disorders.
Schizophr Bull. 2020 Jul 8;46(4):752-757. doi: 10.1093/schbul/sbaa051.
9
Functional exhaustion of antiviral lymphocytes in COVID-19 patients.
Cell Mol Immunol. 2020 May;17(5):533-535. doi: 10.1038/s41423-020-0402-2. Epub 2020 Mar 19.
10
Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients.
Cell Mol Immunol. 2020 May;17(5):541-543. doi: 10.1038/s41423-020-0401-3. Epub 2020 Mar 17.
Zotero 插件